This is a clinical trial designed to test the hypothesis that measuring the absorption and excretion of inhaled mannitol will provide a clinically useful marker of airway epithelial permeability in asthma.
A cohort of subjects with asthma and healthy controls will be exposed to inhaled mannitol according to FDA approved protocols for bronchoprovocation. Mannitol will be measured in the bloodstream and urine and used to determine an airway permeability index. This is a proof of concept study and not a trial of new therapeutics.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
100
Subjects will be challenged with inhaled mannitol according to already approved protocols.
University of Rochester Medical Center
Rochester, New York, United States
Airway permeability index (Urinary clearance of mannitol overtime)
Urinary clearance of mannitol overtime
Time frame: 24 hours
Absorption of mannitol (Absorption and clearance of mannitol from the bloodstream)
Absorption and clearance of mannitol from the bloodstream
Time frame: 6 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.